Best Options Strategy for RVMD
Looking for the best options strategy for Revolution Medicines, Inc. (RVMD)? There is no single answer — the right play depends on your outlook, your risk tolerance and current implied volatility. Below, our free engine shows the highest-scoring defined-risk strategy on the live RVMD option chain right now, and a simple map from your view on RVMD to the strategy that fits it. Model any of them in the calculator before you trade.
About RVMD
Revolution Medicines, Inc. (RVMD) is a major company in Biotechnology. Options traders on RVMD tend to watch , since these can drive large moves in the share price.
About Revolution Medicines, Inc.
Revolution Medicines is a clinical-stage biopharmaceutical company focused on oncology treatments targeting RAS-driven cancers. The company develops two main categories of drugs: RAS inhibitors that directly bind to mutated RAS proteins, designed to work either alone or paired with other therapies, and companion inhibitors that address secondary pathways that help sustain these cancers. Its lead candidate, daraxonrasib, is currently in a phase 3 trial combined with zoldonrasib for pancreatic cancer patients. The pipeline also includes elironrasib for solid tumors in early testing, along with several development-stage compounds targeting different RAS mutations including G12V, Q61H, and G13C variants.
The company generates no meaningful revenue at this stage, as it remains entirely focused on drug development rather than commercialization. Its business model centers on advancing its pipeline candidates through clinical trials toward regulatory approval, with the potential to eventually license or commercialize approved therapies. Founded in 2014 and based in Redwood City, California, Revolution Medicines operates in the competitive oncology drug development space where success…
Today's top-scoring strategy for RVMD
Our engine ranks defined-risk strategies on the live RVMD chain by probability of profit and risk/reward, then surfaces the best-scoring one. It is an educational illustration, not advice.
| Action | Qty | Type | Strike | Premium |
|---|---|---|---|---|
| Buy | 1× | PUT | $180 | $5.75 |
| Sell | 1× | PUT | $200 | $12.80 |
| Sell | 1× | CALL | $200 | $16.20 |
| Buy | 1× | CALL | $240 | $2.55 |
Simulation
Forward simulation of 6,000 lognormal price paths to expiration — not a historical backtest.
Strategy analysis
Greeks vs price
Price × volatility (today)
| −30% | −15% | IV | +15% | +30% | |
|---|---|---|---|---|---|
| $253 | −$1,327 | −$1,183 | −$1,077 | −$1,001 | −$945 |
| $243 | −$1,019 | −$912 | −$844 | −$800 | −$770 |
| $233 | −$642 | −$604 | −$590 | −$587 | −$589 |
| $223 | −$234 | −$287 | −$334 | −$375 | −$409 |
| $213 | $139 | $4 | −$99 | −$177 | −$239 |
| $203 | $405 | $227 | $93 | −$9 | −$89 |
| $192 | $516 | $354 | $223 | $117 | $31 |
| $182 | $479 | $381 | $283 | $194 | $115 |
| $172 | $354 | $329 | $280 | $222 | $163 |
| $162 | $220 | $242 | $237 | $212 | $177 |
| $152 | $128 | $161 | $178 | $179 | $166 |
Live scan from 2026-08-14 · quotes delayed ~15 minutes
Historical backtest: how a Iron Butterfly on RVMD would have performed
We approximated a Iron Butterfly on RVMD, entered repeatedly over the past year (92 historical entries, each held to expiration) with Black-Scholes-modelled entry premiums. Here is how that would have played out on real RVMD price history — an educational backtest, not a prediction of future returns.
Approximate: entry premiums are modelled with Black-Scholes from trailing realised volatility, held to expiration and settled against the real historical close. Real fills, implied volatility and slippage differ — treat it as directional context, not exact returns.
Implied volatility
RVMD is currently trading with high implied volatility, which makes its options expensive — and attractive to sell. On the options we scanned that was around 57% implied volatility, and higher implied volatility means richer premiums and wider expected moves.
Options on RVMD currently price in about 57% implied volatility, versus roughly 38% the stock has actually realised over the past month. That makes options relatively expensive — an edge for strategies that sell premium, such as credit spreads and iron condors.
RVMD's IV Rank is 100/100: implied volatility sits 100% of the way between its 11-day low (54%) and high (57%), and is above 92% of recorded days. Premium is historically rich, which favours net-credit strategies like credit spreads and iron condors.
Off that volatility, the options market is pricing a move of about ±$35.43 (±17%) in RVMD by 2026-09-18 — a range of roughly $167 to $238. Strikes inside that band hold most of the premium and see most of the action.
Across strikes, downside puts on RVMD trade at a higher implied volatility than upside calls — the market is paying up for crash protection. That skew favours selling put spreads or buying calls over symmetric trades.
RVMD options chain highlights: open interest, volume and skew
The live RVMD options chain shows a put/call open-interest ratio of 0.27 (bullish-leaning (more calls)), with at-the-money implied volatility near 57.4%. Open interest clusters at the $230 call — a common resistance "wall" — and the $125 put, a support "wall": the strikes option writers are most exposed to into expiration.
Snapshot of open interest, volume and implied volatility for the nearest scanned expiration — context, not a trading signal.
RVMD insider trading activity (SEC Form 4)
Open-market insider transactions at RVMD over roughly the last six months, from SEC Form 4 filings. Open-market buys are the rarer, more telling signal — routine selling under pre-arranged plans is common, so read a net-selling figure with that in mind.
| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| Patel Sushil | Sell | 881 | $170K | 2026-06-29 |
| Patel Sushil | Sell | 541 | $104K | 2026-06-29 |
| Patel Sushil | Sell | 600 | $114K | 2026-06-29 |
| Patel Sushil | Sell | 100 | $19K | 2026-06-29 |
| Patel Sushil | Sell | 300 | $56K | 2026-06-29 |
| Patel Sushil | Sell | 858 | $160K | 2026-06-29 |
Source: SEC Form 4 filings via Finnhub. Open-market purchases (P) and sales (S) only — grants, option exercises, gifts and tax withholding are excluded. Informational context, not investment advice.
Liquidity and tradeability
RVMD options are thinly traded, with wide bid-ask spreads around 21.3% near the money that eat into any edge — favour simple single-leg or tight defined-risk trades, and always use limit orders.
Earnings & IV crush
RVMD's next earnings report is due around November 4, 2026. Options that expire after it price in a binary move, so their implied volatility is elevated and usually collapses right after the announcement — an "IV crush". If your expiration falls before this date, the trade sidesteps the event.
Key figures
- Market cap
- $41.9B
- Beta (vs market)
- 1.40
- 52-week range
- $34.00–$198.29 (100% up the range)
- Short interest
- 7.0% of float · 4.4 days to cover
Other strong setups for RVMD
If your view on RVMD differs, these also scored well in the latest scan:
How to choose an options strategy for RVMD
Start with your outlook on RVMD, then match it to a defined-risk structure. Here are the most common choices and when each makes sense:
Bullish
Buy a call for leverage with capped risk, or a bull call spread to lower the cost and breakeven when you have a target price.
Long Call → Bull Call Spread →Bearish
Buy a put to profit from a decline with defined risk, or a bear put spread to cheapen the trade when you expect a measured move down.
Long Put → Bear Put Spread →Neutral
Sell an iron condor to collect premium while RVMD stays between two strikes, or write a covered call against shares you already own.
Iron Condor → Covered Call →⧉ Embed this free calculator on your site →
How we pick the best strategy
For each ticker we pull the live option chain, build every supported strategy around the at-the-money strikes, and score them on probability of profit, risk/reward and capital efficiency — favouring defined-risk structures where the maximum loss is known up front. Methodology →
Open RVMD in the free calculator →
Frequently asked questions
What is the best options strategy for RVMD?
It depends on your outlook. Bullish traders often use a long call or bull call spread on RVMD; bearish traders a long put or bear put spread; neutral traders an iron condor or covered call. Our live scan above shows the current highest-scoring defined-risk play.
Are RVMD options liquid enough to trade?
Revolution Medicines, Inc. (RVMD) is among the most actively-traded US options, which usually means tight bid/ask spreads and plenty of strikes and expirations — though you should always check the open interest and spread on the exact contract.
How much money do I need to trade RVMD options?
Buying a single RVMD call or put can cost as little as the premium (often one to a few hundred dollars), while income strategies like a cash-secured put need enough capital to buy 100 shares if assigned.
Is this financial advice?
No. Everything here is educational and uses delayed, third-party data. It is not a recommendation to trade RVMD or any security. Do your own research.
What does Revolution Medicines, Inc. do?
Revolution Medicines, Inc. (RVMD) operates in the Biotechnology industry. The "About Revolution Medicines, Inc." section above gives a fuller picture of what the company does and how it earns money.
Does Revolution Medicines, Inc. pay a dividend?
We don't show a confirmed dividend yield for Revolution Medicines, Inc. here, so treat it as uncertain: before writing calls, check its current dividend and ex-dividend date with your broker — an approaching ex-dividend date can trigger early assignment on in-the-money short calls.
When does Revolution Medicines, Inc. next report earnings?
Revolution Medicines, Inc.'s next earnings are expected around November 4, 2026. Implied volatility usually climbs into the report and drops sharply afterwards (IV crush) — important for any options position held over the date.
Price trend
Tickers related to RVMD
Comparing RVMD with similar names can help you choose the best options strategy:
Company information
- Headquarters
- 700 Saginaw Drive, Redwood City, CA, 94063, United States
- Industry
- Biotechnology
- Employees
- 883
- CEO
- Dr. Mark A. Goldsmith M.D., Ph.D.
- Phone
- 650 481 6801
- Website
- www.revmed.com
Best Options Strategy by Ticker →
Educational use only. Quotes are delayed ~15 minutes and nothing here is financial advice. Options trading involves substantial risk of loss. Privacy · Terms.